• Nenhum resultado encontrado

Rev. Hosp. Clin. vol.55 número4

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Hosp. Clin. vol.55 número4"

Copied!
2
0
0

Texto

(1)

REV. HOSP. CLÍN. FAC. MED. S. PAULO 55(4):111-112, 2000 JULY-AUGUST

EDITORIAL

EVIDENCE-BASED MEDICINE

Mário Cícero Falcão

FALCÃO M - Evidence-based Medicine. Rev. Hosp. Clín. Fac. Med. S. Paulo 55(4):111-112, 2000.

“Evidence based Medicine argues for the fundamental separibility of expertise from expert and of knowledge from knower, and the distillation of medical truth outside the clinical encounter would seem to allow both buyers and sellers in the health care market to act independently and rationally.”

Tannenbaum, 1993

The history of the development of medicine has both triumphs and disas-ters. The assimilation of ineffective, useless, or harmful therapeutic innova-tions can be widely demonstrated. Nowadays, ever more powerful thera-pies are being introduced and dissemi-nated. Are rigorous scientific standards for assessing their efficacy and effec-tiveness being met?

Many questions must be resolved regarding treatment, for example the magnitude of the risk, the economic costs, the consequences, the side ef-fects, and to whom these results may be applicable.

Researchers may sometimes come up with wrong answers because of bias, imprecision, or inaccuracy; even a valid conclusion can not be general-ized. Therefore to rigorously evaluate new therapies, physicians need to

un-derstand the methodology of studies very well before utilizing the results.

The comparison of many trials of an intervention, called meta-analysis, seeks to obtain an estimated summary of the effect of each intervention. The opportunity to draw more definitive conclusions from similar studies is welcome, but a valid overview of ran-domized trials requires predefined in-clusion and exin-clusion criteria, method-ological quality analysis, and a correct tabulation of the results.

A meta-analysis should provide in-creased statistical power, when indi-vidual trials are relatively small, and should also be useful in exploring dif-ferences between studies. It provides a structure for the incorporation of the new evidence in comparable researches performed in the future.

We must explore the dissonance

be-tween the science of objective measure-ment and the art of clinical proficiency and judgment, in order to integrate these different perspectives into clinical meth-ods. An evidence-based approach to clinical decision making is correct or incorrect depending on whether the re-ported clinical observations are objec-tive and, like all scientific measure-ments, reproducible. Empirical observa-tions could be biased unless they are made scientifically and objectively.

Finally, an evidence-based approach encourages the identification of untested interventions, leading to recognition of target areas for future research.

(2)

REV. HOSP. CLÍN. FAC. MED. S. PAULO 55(4):111-112, 2000 JULY-AUGUST

REFERENCES

GREENHALGH T - Narrative based medicine: narrative based medicine in an evidence based world. BMJ 1999; 318:323-5.

SINCLAIR JC - Assessing evidence concerning treatment and prevention of diseases of the newborn. In: SINCLAIR JC, BRACKEN MB.

Effective care of the newborn infant. Oxford, Oxford University Press, 1992, p.3-12.

Referências

Documentos relacionados

This section is intended to encourage a diagnostic approach based on clinical and radiographic findings.. We invite all of our readers

UV-Vis spectra of Carbon dots based on Folic acid (CDs-FA) and its respective reaction mixture before synthesis (RM), along with FA using water as a solvent.. Excitation spectrum

In summary, apart from becom- ing an excellent tool through which information and medical experience can be carried out, the principal ben- efit of the Internet has been to inte-

- Indication of amputation revision in children with transtibial amputation, due to excessive bone growth in the distal extremity of the stump in cases in which the revision

The biochemical investigation al- lowed the diagnosis of 19 MPS cases, classified as follows: Hurler – MPS I (1 case – 5.3%); Hunter – MPS II (2 cases – 10.5%); Sanfilippo – MPS

There was no significant difference on admission between both groups in relation to gender, race, macroscopic tumoral type of tumor according to the Borrmann classification, location

Ma- ternal charts of all deliveries were ret- rospectively reviewed in order to ana- lyze maternal age, fetal sex, type of delivery, type of presentation, presence of prenatal

THE NEONATAL INHALED NITRIC OXIDE STUDY GROUP - Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. ROBERTS JD, FINEMAN JR, MORIN